Home
Dimension Therapeutics, Inc.

Dimension Therapeutics, ... Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domaindimensiontx.com

Year Founded2013

Employees51 - 200

Annual Revenue$15M - $25M

Dimension Therapeutics, Inc.

Dimension Therapeutics, Inc. (including company regionals)

dimensiontx.com

See more website traffic and engagement information

Dimension Therapeutics, Inc. Revenue up to May 2026 is 15M - 25M

revenue generated by Dimension Therapeutics, Inc. top domains

Dimension Therapeutics, Inc. top domains revenue over 3 years

Revenue for Dimension Therapeutics, Inc. top domains

dimensiontx.com15M - 25M

See more with Sales Intelligence

Total visits to Dimension Therapeutics, Inc.'s top domains

Understand Dimension Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Dimension Therapeutics, Inc.'s top domains

Analyze Dimension Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Dimension Therapeutics, Inc.'s top domains

See how Dimension Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Dimension Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Dimension Therapeutics, Inc.

These are the website technologies, by industry, used by Dimension Therapeutics, Inc. top domains

Advertising (4)

Google Adsense

Social (3)

Facebook Connect

Email Services (2)

G Suite

Mobile (2)

Meta Viewport

More Technologies

4

See all

News & Signals from Dimension Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJenkins leaves Dimension Therapeutics, Inc as chief executive officer.Dr Jenkins joins the company from Dimension Therapeutics, where she served as its chief executive officer, and her previous roles have seen her gain expertise in scientific research, clinical development, regulatory process and commercialisation.

NewsDimension Therapeutics, Inc partnered with REGENXBIO Inc. on Aug 1st '17.Cambridge-based Dimension had entered a merger agreement with Regenxbio, announced in August.

NewsDimension Therapeutics, Inc decreased headcount by 74 on Jun 1st '17.In June, after scrapping its lead drug due to disappointing trial results, Dimension announced plans to cut its workforce from 74 employees to around 56 by year-end, but the company has repeatedly declined to disclose its headcount during the negotiations.